Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Ottavio Alfieri , Michele De Bonis Added: 3 years ago
Despite the absence of randomised comparison, it is widely accepted that, when feasible, valve repair is the optimal surgical treatment in patients with severe degenerative mitral regurgitation (MR) due to the well documented advantages of such an approach over valve replacement in terms of perioperative mortality, preservation of postoperative left ventricular (LV) function and long-term… View more
Author(s): Eduardo Alegria-Barrero , Olaf W Franzen Added: 3 years ago
Diseases of the mitral valve (MV) are the second most frequent clinically significant form of valvular disease in adults. In particular, MV regurgitation occurs with increasing frequency as part of degenerative changes in the ageing process.1 The annual incidence of degenerative MV disease is estimated at approximately 2–3 %. In addition to degenerative valve disease, MV regurgitation can be… View more
Author(s): Kashish Goel , Colin M Barker , JoAnn Lindenfeld Added: 3 years ago
Heart failure (HF) is a growing epidemic, with an estimated 6.2 million adults (≥20 years) affected between 2013 and 2016 in the US.1 The prevalence is increasing and is expected to reach 8 million by 2030.1 Mitral regurgitation (MR) is common in HF patients, especially in those with ischaemia, left ventricular (LV) dysfunction or dilated cardiomyopathy. MR in the absence of structural… View more
Author(s): Jacob Green , Vasilis Babaliaros , Peter Block Added: 3 years ago
Mitral regurgitation (MR) is the most prevalent form of valvular heart disease. Its major causes are primary mitral leaflet abnormalities (valve prolapse, healed endocarditis, or rheumatic disease), primary myocardial disease (functional MR), and ischemic disease. Even with severe MR, affected individuals may remain asymptomatic for long periods of time.1 The early, compensated state of MR is… View more
Author(s): Alexandra Gonçalves , Carla Sousa , José Alberto de Agustín , et al Added: 3 years ago
Valvular disease is the most prevalent structural heart disease among adults and its burden is growing along with the increase in life expectancy.1 Mitral regurgitation (MR) is the second most frequent valvular disease, after aortic stenosis. Its natural history is very variable and highly dependent on the presence of symptoms. However, even in asymptomatic patients, the prognosis of severe MR is… View more
Author(s): Antonio Popolo Rubbio Added: 1 year ago
In this short video, Dr Antonio Popolo Rubbio (IRCCS Policlinico San Donato, IT) shares the key findings from a study that assessed the use of the MitraClip in patients with atrial functional mitral regurgitation. Discussion Points 1. Study Background 2. Mitraclip Procedure 3. Study Design & the Patient Selection Criteria 4. Key Findings 5. Which Patients Would Benefit the Most from this… View more
Author(s): Mehmet Ali Elbey , Luis Augusto Palma Dallan , Guilherme Ferragut Attizzani Added: 3 years ago
The field of mitral valve disease diagnosis and management is in constant change. New understanding of disease pathology and progression, with improvements in and increased use of sophisticated imaging modalities have led to more complex treatments. Transcatheter mitral valve repair with a MitraClip device is resulting in good outcomes in patients with primary mitral regurgitation who are at high… View more